340 related articles for article (PubMed ID: 27785777)
1. Current Management of Childhood Acute Myeloid Leukemia.
Rubnitz JE
Paediatr Drugs; 2017 Feb; 19(1):1-10. PubMed ID: 27785777
[TBL] [Abstract][Full Text] [Related]
2. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
[TBL] [Abstract][Full Text] [Related]
3. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
[TBL] [Abstract][Full Text] [Related]
4. Straight to the Point-The Novel Strategies to Cure Pediatric AML.
Lejman M; Dziatkiewicz I; Jurek M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216084
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia in children: Current status and future directions.
Taga T; Tomizawa D; Takahashi H; Adachi S
Pediatr Int; 2016 Feb; 58(2):71-80. PubMed ID: 26645706
[TBL] [Abstract][Full Text] [Related]
6. Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?
DeAngelo DJ; Stein EM; Ravandi F
Am Soc Clin Oncol Educ Book; 2016; 35():e302-12. PubMed ID: 27249736
[TBL] [Abstract][Full Text] [Related]
7. Advances in treatment of de-novo pediatric acute myeloid leukemia.
Ribeiro RC
Curr Opin Oncol; 2014 Nov; 26(6):656-62. PubMed ID: 25226383
[TBL] [Abstract][Full Text] [Related]
8. Pediatric acute myeloid leukemia: towards high-quality cure of all patients.
Kaspers GJ; Zwaan CM
Haematologica; 2007 Nov; 92(11):1519-32. PubMed ID: 18024401
[TBL] [Abstract][Full Text] [Related]
9. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual disease.
Appelbaum FR
Best Pract Res Clin Haematol; 2015; 28(2-3):133-40. PubMed ID: 26590770
[TBL] [Abstract][Full Text] [Related]
11. Unfavorable-risk acute myeloid leukemia dissected.
Strickland SA; Mohan SR; Savona MR
Curr Opin Hematol; 2016 Mar; 23(2):144-9. PubMed ID: 26825699
[TBL] [Abstract][Full Text] [Related]
12. What are the most promising new agents in acute myeloid leukemia?
Sallman DA; Lancet JE
Curr Opin Hematol; 2017 Mar; 24(2):99-107. PubMed ID: 28030373
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia: advancing clinical trials and promising therapeutics.
Daver N; Cortes J; Kantarjian H; Ravandi F
Expert Rev Hematol; 2016 May; 9(5):433-45. PubMed ID: 26910051
[TBL] [Abstract][Full Text] [Related]
14. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
16. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.
Falini B; Martelli MP
Best Pract Res Clin Haematol; 2015; 28(2-3):90-7. PubMed ID: 26590764
[TBL] [Abstract][Full Text] [Related]
17. Management of AML: who do we really cure?
Liesveld J
Leuk Res; 2012 Dec; 36(12):1475-80. PubMed ID: 22938830
[TBL] [Abstract][Full Text] [Related]
18. Therapy of childhood acute myelogenous leukemias.
Vormoor J; Boos J; Stahnke K; Jürgens H; Ritter J; Creutzig U
Ann Hematol; 1996 Jul; 73(1):11-24. PubMed ID: 8695718
[TBL] [Abstract][Full Text] [Related]
19. AML evolution from preleukemia to leukemia and relapse.
Shlush LI; Mitchell A
Best Pract Res Clin Haematol; 2015; 28(2-3):81-9. PubMed ID: 26590763
[TBL] [Abstract][Full Text] [Related]
20. The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan.
Yeh TC; Liu HC; Wang LY; Chen SH; Lin WY; Liang DC
J Pediatr Hematol Oncol; 2007 Dec; 29(12):826-31. PubMed ID: 18090930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]